Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer

Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone

(2012) Jung Hun Kang et al.   JOURNAL OF CLINICAL ONCOLOGY

Resection of liver metastases is beneficial in patients with gastric cancer: report on 15 cases and review of literature

(2011) Yves Dittmar et al.   Gastric Cancer

Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study

(2011) Atsushi Ohtsu et al.   JOURNAL OF CLINICAL ONCOLOGY

Outcomes for patients following hepatic resection of metastatic tumors from gastric cancer

(2010) Hironori Tsujimoto et al.   Hepatology International

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Strategies for treating liver metastasis from gastric cancer

(2010) Yoshihiro Kakeji et al.   SURGERY TODAY

Liver resections in metastatic gastric cancer

(2010) Sid P. Kerkar et al.   HPB

Treatment for colorectal liver metastases: a review

(2009) Hiroshi Shimada et al.   LANGENBECKS ARCHIVES OF SURGERY

Radiofrequency Ablation for Metachronous Hepatic Metastases From Gastric Cancer

(2009) Hyung Ook Kim et al.   SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES

Prognostic Factors for Survival in Patients with Hepatic Recurrence After Curative Resection of Gastric Cancer

(2009) Si-Eun Hwang et al.   WORLD JOURNAL OF SURGERY

Radiofrequency Ablation for Hepatic Metastasis from Gastric Adenocarcinoma

(2009) Ji Yeong An et al.   YONSEI MEDICAL JOURNAL

Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases

(2008) S. H. Cheon et al.   ANNALS OF ONCOLOGY

Liver resection for metastatic gastric cancer

(2008) A. Thelen et al.   EJSO

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

(2008) Wasaburo Koizumi et al.   LANCET ONCOLOGY